HomeACADEMIA
ACADEMIA

Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer
(Mar.23.2016)

The Japanese Gastric Cancer Association (JGCA) is revising the guidelines for the treatment of gastric cancer. Evidence from a number of clinical trials to be announced going forward is expected to be reflected in the revised guidelines’ recommendations on chemotherapy. It plans to announce the revised guidelines in 2017, which would be the third year since their last revision ...
(LOG IN FOR FULL STORY)

News Calendar